129 related articles for article (PubMed ID: 25651501)
1. Promoting safe use of isotretinoin by increasing contraceptive knowledge.
Leger MC
JAMA Dermatol; 2015 Apr; 151(4):393-4. PubMed ID: 25651501
[No Abstract] [Full Text] [Related]
2. Promoting safe use of isotretinoin by increasing contraceptive knowledge.
Werner CA; Papic MJ; Ferris LK; Schwarz EB
JAMA Dermatol; 2015 Apr; 151(4):389-93. PubMed ID: 25650743
[TBL] [Abstract][Full Text] [Related]
3. Isotretinoin and pregnancy prevention: do we need to take a long, hard look at ourselves?
Altman EM
JAMA Dermatol; 2014 Apr; 150(4):361-2. PubMed ID: 24258339
[No Abstract] [Full Text] [Related]
4. We Pledge to Change iPLEDGE.
Pierson JC; Ferris LK; Schwarz EB
JAMA Dermatol; 2015 Jul; 151(7):701-2. PubMed ID: 25853235
[No Abstract] [Full Text] [Related]
5. Women's experiences with isotretinoin risk reduction counseling.
Werner CA; Papic MJ; Ferris LK; Lee JK; Borrero S; Prevost N; Schwarz EB
JAMA Dermatol; 2014 Apr; 150(4):366-71. PubMed ID: 24258663
[TBL] [Abstract][Full Text] [Related]
6. Family physicians and accutane.
Van Durme DJ
Am Fam Physician; 2000 Oct; 62(8):1772, 1774, 1777. PubMed ID: 11057835
[No Abstract] [Full Text] [Related]
7. Simplifying contraception requirements for iPLEDGE: A decision analysis.
Barbieri JS; Roe AH; Mostaghimi A
J Am Acad Dermatol; 2020 Jul; 83(1):104-108. PubMed ID: 32068040
[TBL] [Abstract][Full Text] [Related]
8. Program to prevent pregnancy while on medication.
Barnes-Nelson N
J Natl Med Assoc; 2002 Feb; 94(2):A10-1. PubMed ID: 11853052
[No Abstract] [Full Text] [Related]
9. Healthcare professional surveys to investigate the implementation of the isotretinoin Pregnancy Prevention Programme: a descriptive study.
Crijns I; Mantel-Teeuwisse A; Bloemberg R; Pinas E; Straus S; de Jong-van den Berg L
Expert Opin Drug Saf; 2013 Jan; 12(1):29-38. PubMed ID: 23163396
[TBL] [Abstract][Full Text] [Related]
10. Pregnancy prevention among women taking isotretinoin: failure to comply with the recommendations.
Boucher N; Beaulac-Baillargeon L
Can Fam Physician; 2006 Mar; 52(3):338-9. PubMed ID: 16926960
[TBL] [Abstract][Full Text] [Related]
11. Isotretinoin on TikTok™: misinformation getting under our skin.
Chen MKY; Garden F; Sebaratnam DF
Clin Exp Dermatol; 2021 Dec; 46(8):1606-1607. PubMed ID: 34155690
[No Abstract] [Full Text] [Related]
12. The effect of drug consultation center guidance on contraceptive use among women using isotretinoin: a randomized, controlled study.
Tsur L; Kozer E; Berkovitch M
J Womens Health (Larchmt); 2008 May; 17(4):579-84. PubMed ID: 18447762
[TBL] [Abstract][Full Text] [Related]
13. Menstrual irregularity during isotretinoin treatment.
Kwon HJ; Lee JY; Cho BK; Park HJ
J Eur Acad Dermatol Venereol; 2007 Apr; 21(4):562-3. PubMed ID: 17374003
[No Abstract] [Full Text] [Related]
14. Isotretinoin in retrospect.
Karadag AS; Parish LC; Lambert WC
Clin Dermatol; 2017; 35(3):335-339. PubMed ID: 28511833
[No Abstract] [Full Text] [Related]
15. The power of Accutane. The benefits and risks of a breakthrough acne drug.
Meadows M
FDA Consum; 2001; 35(2):18-23. PubMed ID: 11444244
[No Abstract] [Full Text] [Related]
16. Isotretinoin and pregnancy.
Jones KL; Adams J; Chambers CD; Erickson JD; Lammer E; Polifka J;
JAMA; 2001 Apr; 285(16):2079-81. PubMed ID: 11311094
[No Abstract] [Full Text] [Related]
17. Reply letter: are FDA prescription drug safety plans working? A case study of isotretinoin.
Fain K; Alexander GC
Pharmacoepidemiol Drug Saf; 2014 Apr; 23(4):440-1. PubMed ID: 24706420
[No Abstract] [Full Text] [Related]
18. Are Food and Drug Administration prescription drug safety plans working? A case study of isotretinoin.
Fain K; Alexander GC
Pharmacoepidemiol Drug Saf; 2013 Dec; 22(12):1258-62. PubMed ID: 24115318
[No Abstract] [Full Text] [Related]
19. Comments on: are Food and Drug Administration prescription drug safety plans working? A case study of isotretinoin.
Van Bennekom CM; Mitchell AA
Pharmacoepidemiol Drug Saf; 2014 Apr; 23(4):439. PubMed ID: 24706419
[No Abstract] [Full Text] [Related]
20. Caring for women with childbearing potential taking teratogenic dermatologic drugs. Guidelines for practice.
Perlman SE; Rudy SJ; Pinto C; Townsend-Akpan C
J Reprod Med; 2001 Feb; 46(2 Suppl):153-61. PubMed ID: 11255823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
